FOSAMPRENAVIR vs FOSAPREPITANT DIMEGLUMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAMPRENAVIR vs FOSAPREPITANT DIMEGLUMINE: Safety Overview
| Metric | FOSAMPRENAVIR | FOSAPREPITANT DIMEGLUMINE |
|---|---|---|
| Total FAERS Reports | 460 | 888 |
| Deaths Reported | 31 | 118 |
| Death Rate | 6.7% | 13.3% |
| Hospitalizations | 91 | 364 |
| Average Patient Age | 45.3 yrs | 57.0 yrs |
| % Female Patients | 27.9% | 50.1% |
| FDA Approval Date | Apr 15, 2016 | Aug 20, 2020 |
| Manufacturer | Sun Pharmaceutical Industries, Inc. | Dr. Reddy's Laboratories Inc., |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Discontinued |